RxDoctor Payments DataLook up a doctor →

Louis Korman

Gastroenterology · Chevy Chase, MDNPI 1447229968

Payments from drug & device makers

$1,894,755in general payments, 2019–2025

Across 668 payments — averaging $2836.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$574K
  • AbbVie$541K
  • Gilead$235K
  • Pfizer$180K
  • Takeda Pharmaceuticals U.S.A., Inc.$101K
  • Bristol Myers Squibb$86K
  • plus $177K from 21 others
$1,328in research payments, 2019–2025

Across 11 payments — averaging $120.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,894,755 in reported general payments places this provider in the 95th percentile of 455 gastroenterology providers in Maryland.

See all gastroenterology providers in Maryland

Other gastroenterology in Chevy Chase

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →